CRChester S. Reft

Chester S. Reft

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chester S. Reft has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Leon Myrianthopoulos

    Department of Radiation and Cellular Oncology, The University of Chicago, 5841 South Maryland Avenue, Chicago, Illinois 60637

    1 shared publication
  • Renate Runkel‐Muller

    Radiation Oncology Center, St Margaret Mercy Healthcare Centers, Hammond, Indiana 46320

    1 shared publication

Latest Publications

  • The energy dependence and dose response of a commercial optically stimulated luminescent detector for kilovoltage photon, megavoltage photon, and electron, proton, and carbon beams

    by Chester S. Reft

    Optically stimulated luminescent detectors, which are widely used in radiation protection, offer a number of potential advantages for application in radiation therapy dosimetry. Their introduction into this field has been somewhat hampered by the lack of information on their radiation response in megavoltage beams. Here the response of a commercially available optically stimulated luminescent detector (OSLD) is determined as a function of energy, absorbed dose to water, and linear energy transfer (LET). The detector response was measured as a function of energy for absorbed doses from 0.5 to 4.0 Gy over the following ranges: 125 kVp to18 MV for photons, 6–20 MeV for electrons, 50–250 MeV for protons, and 290 MeV/u for the carbon ions. For the low LET beams, the response of the detector was linear up to 2 Gy with supralinearity occurring at higher absorbed doses. For the kilovoltage photons, the detector response relative to 6 MV increased with decreasing energy due to the higher atomic number of aluminum oxide (11.2) relative to water (7.4). For the megavoltage photons and electrons, the response was independent of energy. The response for protons was also independent of energy, but it was about 6% higher than its response to 6 MV photons. For the carbon ions, the dose response was linear for a given LET from 0.5 to 4.0 Gy, and no supralinearity was observed. However, it did exhibit LET dependence on the response relative to 6 MV photons decreasing from 1.02 at to 0.41 at . These results provide additional information on the dosimetric properties for this particular OSL detector and also demonstrate the potential for their use in photon, electron, and proton radiotherapy dosimetry with a more limited use in high LET radiotherapy dosimetry.


  • In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing IMRT

    by Chester S. Reft, Renate Runkel‐Muller, Leon Myrianthopoulos

    For intensity modulated radiation therapy (IMRT) treatments photons are typically used, however, for deep seated tumors in the pelvic region, higher photon energies are increasingly being employed. IMRT treatments require more monitor units (MU) to deliver the same dose as conformal treatments, causing increased secondary radiation to tissues outside the treated area from leakage and scatter, as well as a possible increase in the neutron dose from photon interactions in the machine head. Here we provide in vivo patient and phantom measurements of the secondary out‐of‐field photon radiation and the neutron dose equivalent for IMRT treatments. The patients were treated for prostate cancer with IMRT at institutions using different therapy machines and treatment planning systems. Phantom exposures at the different facilities were used to compare the secondary photon and neutron dose equivalent between typical IMRT delivered treatment plans with a six field three‐dimensional conformal radiotherapy (3DCRT) plan. For the in vivo measurements thermoluminescent detectors (TLDs) and detectors using optically stimulated radiation were used to obtain the photon dose and CR‐39 track etch detectors were used to obtain the neutron dose equivalent. For the phantom measurements a Bonner sphere ( diameter) containing two types of TLDs (TLD‐600 and TLD‐700) having different thermal neutron sensitivities were used to obtain the out‐of‐field neutron dose equivalent. Our results showed that for patients treated with IMRT the photon dose equivalent is greater than the neutron dose equivalent measured outside the treatment field and the neutron dose equivalent normalized to the prescription dose varied from 2 to among the therapy machines. The Bonner sphere results showed that the ratio of neutron equivalent doses for the IMRT and 3DCRT prostate treatments scaled as the ratio of delivered MUs. We also observed differences in the measured neutron dose equivalent among the three therapy machines for both the in vivo and phantom exposures.